SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-006211
Filing Date
2018-01-09
Accepted
2018-01-08 18:22:08
Documents
9
Period of Report
2018-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d481483d8k.htm 8-K 16177
2 EX-99.1 d481483dex991.htm EX-99.1 29940
3 GRAPHIC g481483page1.jpg GRAPHIC 281423
4 GRAPHIC g481483page2.jpg GRAPHIC 182291
5 GRAPHIC g481483page3.jpg GRAPHIC 71714
6 GRAPHIC g481483page4.jpg GRAPHIC 80025
7 GRAPHIC g481483page5.jpg GRAPHIC 77118
8 GRAPHIC g481483page6.jpg GRAPHIC 73509
9 GRAPHIC g481483page7.jpg GRAPHIC 70027
  Complete submission text file 0001193125-18-006211.txt   1199257
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 18517494
SIC: 2834 Pharmaceutical Preparations